Thursday, 3 December 2020

PHARMACOLOGY 2021

About Conference


Pharmacology Conferences | Toxicology Conferences | Clinical Pharmacology Conferences 2020 | World Congress on Pharmacology

Conference Series LLC Ltd invites all the participants across the globe to attend 34th  World Congress on Pharmacology during August 16-17, 2021 at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharmacology 2021 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacolo­gy one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat ac­cordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.

Conference Highlights


Track 01: Pharmacology
Pharmacology is a branch in science concerned with the effects of the drugs on living organisms (pharmacodynamics) and the effects of living organisms with the drugs (pharmacokinetics). This subject embodies drug composition and properties, interactions, toxicology, therapy, and medicinal uses such as application and antipathogenic capabilities. Pharmacology is subdivided into two categories as mentioned above, pharmacodynamics and pharmacokinetics. Pharmacodynamics deals with chemical interactions with body/cell receptors. Pharmacokinetics, on the other hand, deals with the four stages of chemicals passing through the body: absorption, distribution, metabolism and excretion.
International conference on Pediatric Pathology January 16-17, 2020 Lisbon, Portugal; 2nd International Conference on Medical and Molecular Pathology February 12-13, 2020 Paris   France ;16th International Conference on Surgical Pathology & Cancer Diagnosis March 23-24, 2020 London, UK; 5th Global Pediatric Ophthalmology Congress March 02-03, 2020 Rome, Italy; World Congress on Ophthalmology & Optometry April 13-14, 2020 London, UK;
29th International Conference on Insights in Ophthalmology June 17-18, 2020 London, UK; 19th Asia Pacific Ophthalmologists Annual Meeting October 19-20, 2020 Singapore; 32nd International Conference on Cancer Research and Therapy February 17-18-2020 Osaka, Japan;
Related Societies:
Track 02: Neuro Pharmacology
Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology focuses on the study of how drugs affect human behavior (neuropsychopharmacology), including the study of how drug dependence and addiction affect the human brain. Molecular neuropharmacology involves the study of neurons and their neurochemicallinteractions, with the overall goal of developing drugs that have beneficial effects on neurological function. Both of these fields are closely connected, since both are concerned with the interactions of neurotransmitters, neuropeptides neuro hormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Studying these interactions, researchers are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.
4th Global Summit on Cancer November 11-12, 2020 Tokyo, Japan; 40th Euro Congress on Cancer Science & Therapy March 09-10, 2020 Rome, Italy; 20th Global Cancer Summit March 30-31, 2020 Kyoto, Japan; 5th World Congress on Frontiers in Cancer Research and Therapy April, 13-14, 2020 Tokyo, Japan; World Congress on Women Oncology & Care April 14-15, 2020 Tokyo , Japan; 11th EURO BREAST CANCER SUMMIT April 29-30, 2020 Prague, Czech Republic; 27th Cancer Genomics Congress: New Era for Cancer Prevention June 15-16, 2020 Barcelona, Spain; 5th World Congress on Cancer and Diagnostics June 15-16, 2020 Berlin, Germany; 18th Asia Pacific Oncologists Annual Meeting June 22-23, 2020 Brisbane, Australia; 6th International Conference on Neuro-Oncology and Brain Tumor June 22-23, 2020 Brisbane, Australia; 31st Experts Meet on Cancer Therapy and Immuno Oncology July 13-14, 2020 Singapore;
Related Societies:
Track 03: Toxicology
Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals. It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to the poisoning of humans.
It includes environmental agents and chemical compounds found in nature, as well as pharmaceutical compounds that are synthesized for medical use by humans. These substances may produce toxic effects in living organisms including disturbance in growth patterns, discomfort, disease and death.

International Conference on Tuberculosis and Respiratory Diseases February 10-11, 2020 Paris, France; 1th Annual Congress on Pulmonology & Respiratory Medicine March 18-19, 2020 Amsterdam, Netherlands; 10th International Conference on COPD and Lungs May 25-26, 2020 Kyoto, Japan; 21st World Congress on Gastroenterology March 09-10, 2020 Paris, France ; 15th Annual Congress on Gastroenterology & Hepatology March 30-31, 2020 Hong kong ; 16th World Congress on  Gastroenterology & Therapeutics April 06-07, 2020 Osaka, Japan ; 15th Euro-Global Gastroenterology Conference June 24-25, 2020 Rome, Italy.
Related Societies:
Forensic toxicology is the use of toxicology and other disciplines such as analytical chemistry, pharmacology and clinical chemistry to aid medical or legal investigation of death, poisoning, and drug use. The primary concern for forensic toxicology is not the legal outcome of the toxicological investigation or the technology utilized, but rather the obtainment and interpretation of results. A toxicological analysis can be done to various kinds of samples. A forensic toxicologist must consider the context of an investigation, in particular any physical symptoms recorded, and any evidence collected at a crime scene that may narrow the search, such as pill bottles, powders, trace residue, and any available chemicals. Provided with this information and samples with which to work, the forensic toxicologist must determine which toxic substances are present, in what concentrations, and the probable effect of those chemicals on the person.
2nd International Conference on Pharma Industry and Pharmaceuticals January 20-21, 2020 Hong Kong; 12th International Conference on Medicinal Chemistry and Drug Discovery February 12-13, 2020 Paris, France; 2nd International Conference on Biosimilars & Pharmaceuticals February 12-13, 2020 Auckland, New Zealand; 14th Global Pharmacovigilance and Clinical Trials Summit February 12-13, 2020 Sydney, Australia; 3rdInternational Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine February 24-25, 2020 Rome, Italy; 21st International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 11-12, 2020 Rome, Italy. 22nd Global Obesity Meeting June 25-26, 2020 Tokyo, Japan; 3rd Middle East Obesity, Bariatric Surgery and Endocrinology Congress June 22-23, 2020 Dubai, UAE.
Related Societies:
The Department of Molecular and Clinical Pharmacology is dedicated to define disease processes, understanding both drug actions and adverse reactions, developing novel therapeutic strategies for intervention and optimizing the benefit–risk ratio of current and new drugs. We are based within the Institute of Translational Medicine, whose overall aim is to take basic scientific understanding and translate it into innovations for the benefit of patients, the public and health systems across the world.
7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance March 16-17, 2020 London, UK; 10th International Conference on Clinical Research & Clinical Trials March 18-19, 2020 | Amsterdam, Netherlands; 22nd Annual Medicinal & Pharmaceutical Sciences Congress March 19-20, 2020 Osaka, Japan; 6th International Conference on Antibiotics & Antibiotic Resistance March 23-24, 2020 Barcelona, Spain; 6th Annual Congress on Clinical & Hospital Pharmacy March 25-26, 2020 Singapore; 23rd Asia Pacific Pharma Congress March 25-26, 2020 Singapore; 20th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry April 01-02, 2020 London, UK; 13th European Biosimilars Congress 2020 April 01-02, 2020 London, UK; 16th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology May 04-05, 2020 Amsterdam, Netherlands; Global summit on Cosmetic Surgery & Dermatology May 13-14, 2020 Tokyo, Japan;
Related Societies:
Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to know what is Pharmacovigilance. This track gives a brief discussion on Pharmacovigilance role in healthcare system. Pharmacovigilance legislation gives an outlook on the rules and laws to follow in Pharmacovigilance practice. The Role of Pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines
13th International Conference and Exhibition on Pharmacovigilance & Drug Safety July 27-28, 2020 Zurich Switzerland; Innovation in Drug Design Techniques and Pharmacology October 19-20, 2020 Paris, France; 11th Annual Biomarkers and Clinical Research Congress Mar 23-24 2020 Dublin, Ireland; 13th International Conference on Childhood Obesity and Nutrition March 16-17, 2020 London, UK; 22nd Global Obesity Meeting June 25-26, 2020 Tokyo, Japan; 16th Euro Obesity and Endocrinology Congress July 20-21, 2020 Barcelona, Spain; 3rd Global Experts Meeting on Infectious Diseases January 27-28, 2020 | Bangkok, Thailand.
Related Journals:
Related Associations or Societies:
The pharmaceutical and Toxicological industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
7th Global Congress on Rare Diseases & Orphan Drug May 18-19, 2020 Istanbul, Turkey; 10th European Epidemiology and Public Health Congress May 29-30, 2020 Istanbul, Turkey; 7th International Congress on Infectious Diseases February 24-25, 2020 Berlin, Germany; 15th World Conference on Infectious Diseases, Prevention and Control March 19-20, 2020 Dubai, UAE; 5th Annual Congress on Infectious Diseases March 27-28, 2020 Barcelona, Spain; 9th Asia Pacific STD and Infectious Diseases Congress May 15-16, 2020 Tokyo, Japan; 13th Global Infections Conference October 28-29, 2020  Tokyo, Japan; 16th Global Summit on Hematology and Blood Disorders March 02-03, 2020 London, UK; 18th World Hematology Congress March 16-17, 2020 London, UK;
American Association of Pharmaceutical Scientists (AAPS) October 25 – 29, 2020 New Orleans, LA; Structural, Computational and Pharmacological Approaches for Studying GPCR Function, February 9 - 10, 2019, Ventura, CA, US; World Congress on Advanced Pharmacy and Clinical Research on July 16-17, 2018 Sydney, Australia; How Form, Function, Content and Context Shape GPCR Signaling February 10 - 15, 2019, Boulevard Ventura, CA, US; International conference on Clinical toxicology and pharmacology, 15-17 Oct 2019 Vienna, 1070, Vienna, Austria; 2ndInternational Pharma Conference and Expo, March 20-22, 2019 Frankfurt, Germany; Drug Discovery India 2019 Thursday, 17 January 2019 - Friday, 18 January 2019, Mumbai, India; 7th Edition of International Conference on Pain Management March 25-27, 2019 Rome, Italy; American Association of Pharmaceutical Scientists (AAPS) November 2 – 7, 2019, San Antonio, Texas; 7th FIP Pharmaceutical Sciences World Congress (PSWC) Smart Therapeutics for a Complex World May 22 – 27, 2020 Montreal, QC;
Related Societies:
In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected.
The main goals of pre-clinical studies are to determine the safe dose for first-in-man study and assess a product's safety profile. Products may include new medical devices, drugs, gene therapy solutions and diagnostic tools.
On average, only one in every 5,000 compounds that enters drug discovery to the stage of preclinical development becomes an approved drug.
15th World Conference on Infectious Diseases, Prevention and Control March 19-20, 2020 Dubai, UAE; 5th Annual Congress on Infectious Diseases March 27-28, 2020 Barcelona, Spain; 9th Asia Pacific STD and Infectious Diseases Congress May 15-16, 2020 Tokyo, Japan; 7th Global Congress on Rare Diseases & Orphan Drug May 18-19, 2020 Istanbul, Turkey; 10th European Epidemiology and Public Health Congress May 29-30, 2020 Istanbul, Turkey; 7th International Conference on Infectious Diseases & Antibiotics October 12-13, 2020 Prague, Czech republic; 13th Global Infections Conference October 28-29, 2020 | Tokyo, Japan;
Cardiovascular Pharmacology deals with the study of the effects of drugs upon the heart or circulatory system. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development. The cardiac drugs affect the function of the heart in three main ways. They can affect the force of contraction of the heart muscle (inotropic effects), they can affect the frequency of the heart beat or heart rate (chronotropic effects) or they can affect the regularity of the heart beat (rhythmic effects). Drugs can also affect blood vessels by altering the state of compression of the smooth muscle in the vessel wall, altering its diameter and accordingly directing the volume of blood stream. Such medications are classified as vasoconstrictors or vasodilators depending on the smooth muscle lining contraction and relaxation respectively.
Asia-Pacific Dermatology & Cosmetology Conference February 20-21, 2020 Kuala Lumpur, Malaysia; 20th European Dermatology Congress March 05-06, 2020 | Prague, Czech Republic; 9th International Conference on Cosmetology & Beauty March 11-12, 2020 Rome, Italy; 21st World Dermatology Congress Mar 23-24, 2020 Tokyo , Japan; 2nd Global Summit on Skincare and Plastic Aesthetic March 25-26, 2020 Madrid , Spain ; 22nd World Dermatology and Aesthetic Congress March 26-27, 2020 Abu Dhabi, UAE; 2nd International Meeting on Dermatology, Pathology & Cosmetology April 01-02, 2020 Paris, France; 25th International Conference on Dermatology & Skin Care April 27-28, 2020 Amsterdam, Netherlands; 16th World Conference on Cosmetic Dermatology and Aesthetic Medicine June 22-23, 2020 | Paris, France; 5th International Conference on Aesthetic Medicine and Cosmetology June 25-26, 2020 Bali, Indonesia;
Related Societies:
In a context of severe pharmaceutical pollution, “ecopharmacovigilance” (EPV) has been an area of novel interest. It aims to ensure that significant environmental issues associated with pharmaceuticals in the environment are identified in a timely way, and managed appropriately. EPV has become a research hotspot as a comprehensive and boundary science in Europe and North America, and regulatory requirements governing the comprehensive environmental risk assessment (ERA) of pharmaceuticals exist in these regions. A speedy Chinese pharmaceutical industry development and drug consumption, China should shoulder more international responsibility and contribute to the worldwide EPV. Compared to the west, EPV in China is in its infancy. We analyzed the current state of EPV-related practice in China and found that many efforts have been made by the Chinese government and specialists to control the ever-worsening environmental pharmaceutical pollution problems, including consummating related policies and regulations, revealing the occurrence and behavior of pharmaceutical residues in environment and developing new technologies to improve their removal performance.
24th Global Congress on Biotechnology February 24-25, 2020 London, UK; 15th International Conference on Tissue Engineering and Regenerative Medicine March 18 - 19, 2020 Paris, France; 7th World Congress on Human Genetics and Genetic Diseases March 19-20, 2020 Dubai, UAE; 14th International Conference on Genomics and Molecular Biology March 30-31, 2020 London, UK; International Conference on Organ Donation and Transplantation Science April 08-09,2020 Sydney, Australia; International Conference on Genetic Disorders and Gene Therapy May 18-19, 2020 Osaka, Japan; 24th European Biotechnology Congress(EBC_2020) May 21-22, 2020 London, UK;
Related Societies:
Drug safety testing is happening in a growing number of countries including Austria, Canada, Colombia, Mexico, the Netherlands, Switzerland, United States and the UK. This briefing discusses testing using sophisticated analytical equipment, not DIY kits that cannot identify many contaminants, or strength. Drug safety testing is happening in a growing number of countries including Austria, Canada, Colombia, Mexico, the Netherlands, Switzerland, United States and the UK. This briefing discusses testing using sophisticated analytical equipment, not DIY kits that cannot identify many contaminants, or strength.

American Association of Pharmaceutical Scientists (AAPS) October 25 – 29, 2020 New Orleans, LA; Structural, Computational and Pharmacological Approaches for Studying GPCR Function, February 9 - 10, 2019, Ventura, CA, US; World Congress on Advanced Pharmacy and Clinical Research on July 16-17, 2018 Sydney, Australia; How Form, Function, Content and Context Shape GPCR Signaling February 10 - 15, 2019, Boulevard Ventura, CA, US; International conference on Clinical Toxicology and Pharmacology, 15-17 Oct 2019 Vienna, 1070, Vienna, Austria;2ndInternational Pharma Conference and Expo, March 20-22, 2019 Frankfurt, Germany; Drug Discovery India 2019 Thursday, 17 January 2019 - Friday, 18 January 2019, Mumbai, India;7th Edition of International Conference on Pain Management March 25-27, 2019 Rome, Italy; American Association of Pharmaceutical Scientists (AAPS) November 2 – 7, 2019, San Antonio, Texas; 7th FIP Pharmaceutical Sciences World Congress (PSWC) Smart Therapeutics for a Complex World May 22 – 27, 2020 Montreal, QC;
11th International Congress on Surgery March 30-31, 2020 Kyoto, Japan; 12th International Conference on Surgery and Anesthesia May 13-14,2020 Tokyo, Japan; 14th International Meeting on Anaesthetics & Sedatives May 15-16, 2020 Sydney, Australia; 5th International Conference on Anesthesia June 10-11, 2020 Frankfurt, Germany; 5th European Otolaryngology-ENT Surgery Conference August 24-26, 2020 Barcelona, Spain; 10th World Congress on Frontiers in Plastic Surgery September 14-15, 2020 | Tokyo, Japan; 7th International Conference on Rhinology & Otology October 22-23, 2020 Tokyo, Japan; 18th International Conference on Pharmaceutical Microbiology and Biotechnology February 24-25, 2020 Berlin, Germany.
Related Societies:
Track 12: ImmunoPharmacology
Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs. Hence, the journal encompasses a broad range of pathologies (e.g. acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation, and primary and secondary immunodeficiencies). It is published by Informa
4thInternational Conference on Medical & Clinical Microbiology March 18-19, 2020 | Singapore; 9th Annual Congress on Clinical Microbiology and Infectious Diseases MARCH 27-28, 2020 Barcelona, Spain; 5th World Conference on Applied Microbiology and Beneficial Microbes April 27-28, 2020 Singapore; 23rd World Nursing Education Conference April 15-16, 2020 Tokyo, Japan; 49th World Congress on Microbiology June 15-16, 2020 London, UK; 12th International Virology Summit June 24-25, 2020 Rome, Italy; 15th International Conference on Microbial Interactions & Microbial Ecology August 17-18, 2020 Paris, France.
Ophthalmic diseases include both those analogous to systemic diseases (eg, inflammation, infection, neuronal degeneration) and not analogous (eg, cataract, myopia). Many anterior segment diseases are treated pharmacologically through eye drops, which have an implied therapeutic index of local therapy. Unlike oral dosage forms administered for systemic diseases, eyedrops require patients not only to adhere to treatment, but to be able to accurately perform-ie, instill drops correctly. Anatomical and physiological barriers make topical delivery to the anterior chamber challenging-in some cases more challenging than absorption through the skin, nasal passages, or gut. Treatment of the posterior segment (eg, vitreous, retina, choroid, and optic nerve) is more challenging due to additional barriers. Recently, intravitreal injections have become a standard of care with biologics for the treatment of macular degeneration and other diseases. Although the eye has esterases, hydroxylases, and transporters, it has relatively little CYP450 enzymes. Because it is challenging to obtain drug concentrations at the target site, ocular clinical pharmacokinetics, and thus pharmacokinetic-pharmacodynamic interactions, are rarely available. Ophthalmic pharmaceuticals require consideration of solubility, physiological pH, and osmolarity, as well as sterility and stability, which in turn requires optimal pharmaceutics. Although applied locally, ocular medications may be absorbed systemically, which results in morbidity and mortality (eg, systemic hypotension, bronchospasm, and bradycardia)

18thAsia Pacific Pathology Congress November 25-26, 2020 Tokyo, Japan; 7th International Conference & Exhibition on Herbal & Traditional Medicine January 20-21, 2020 Barcelona, Spain; 10th International Conference and Exhibition on Traditional & Alternative Medicine March 16-17, 2020 Hong Kong; 5th International Conference on Holistic Medicine and Nursing Practice March 21-22, 2020 | Sydney, Australia; European Meeting on Dementia and Alzheimer Rehabilitation April 13-14, 2020 Lisbon, Portugal; 3rd International Conference on Herbal & Traditional Medicine April 27-28, 2020 Dubai, UAE; 31st European Congress on Nanotechnology and Materials Engineering February 12-13, 2020 Paris, France.

Related Societies:
Drug safety testing is happening in a growing number of countries including Austria, Canada, Colombia, Mexico, the Netherlands, Switzerland, United States and the UK. This briefing discusses testing using sophisticated analytical equipment, not DIY kits that cannot identify many contaminants, or strength..

33rd International Conference on Nanomaterials and Nanotechnology MAR 25-26 2020, LONDON,UK; 32nd Nano Congress for Future Advancements June 12-13, 2020 Frankfurt, Germany; 5th Annual Congress on Nanomedicine and Drug Delivery August 10-11,2020 Bangkok, Thailand; 31st World Nano Conference November 22-23, 2020 Barcelona, Spain; 6th World Congress on Medical Imaging & Clinical Research May 11-12, 2020 Vienna, Austria; 50th World Congress on Advanced Nursing Research May 11-12, 2020 |;Vienna, Austria; 22nd International Conference on Advanced Energy Materials and Research July 15-16, 2020 Vienna, Austria; 10th European Chemistry Congress July 15-16, 2020 Vienna, Austria; 7th International Conference on Big Data Analysis and Data Mining July 17 -18 2020 Vienna, Austria; 14th World Congress on Biofuels and Bioenergy September 21-22, 2020 Rome, Italy; 24th International Conference on Food Technology & Processing October 07-08, 2020 Vienna, Austria.

Related Societies:
Clinical pharmacy is the discipline of Pharmacy where pharmacists are meant to provide patient care which helps in optimizing the use of drugs and improves health, wellness, and prevents diseases. This session is dealt with topics like basic components of clinical pharmacy practice Prescribing drugs, Reviewing drug use, Administering drugs, Counseling, Documenting professional services, Consulting, Preventing Medication Errors etc.,
2nd International Conference on Pharma Industry and Pharmaceuticals January 20-21, 2020 Hong Kong; 14th Global Pharmacovigilance and Clinical Trials Summit February 12-13, 2020 Sydney, Australia; 3rdInternational Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine February 24-25, 2020 Rome, Italy; 21st International Conference and Exhibition On Pharmaceutics & Novel Drug Delivery Systems March 11-12, 2020 Rome, Italy; 11th World Congress on Bioavailability and Bioequivalence; 7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance March 16-17, 2020 London, UK; 10th International Conference on Clinical Research & Clinical Trials March 18-19, 2020  Amsterdam, Netherlands; 22nd Annual Medicinal & Pharmaceutical Sciences Congress March 19-20, 2020 Osaka, Japan; 6th International Conference on Antibiotics & Antibiotic Resistance March 23-24, 2020 Barcelona, Spain; 6th Annual Congress on Clinical & Hospital Pharmacy March 25-26, 2020 Singapore; 23rd Asia Pacific Pharma Congress March 25-26, 2020 Singapore.
7th FIP Pharmaceutical Sciences World Congress (PSWC) Smart Therapeutics for a Complex World May 22 – 27, 2020 Montreal, QC; American Association of Pharmaceutical Scientists (AAPS) October 25 – 29, 2020 New Orleans, LA;
Related Societies:
All pharmaceutical researchers know the feeling. Somewhere out there must be that elusive molecule — one that will inhibit this enzyme or activate that receptor in the way they want, and without causing unwanted side-effects. But finding it is another matter. For small-molecule drugs — the mainstay of the pharmaceutical industry — time-consuming and expensive screening is needed to pick out promising candidates from the vast number of natural and synthetic compounds available. Testing large numbers of compounds to see if they produce an appropriate biochemical or cellular effect is usually one of the first steps in the drug-discovery pathway, and ways of making this screening faster, more effective and less expensive are in continual development.
23rd Asia Pacific Pharma Congress March 25-26, 2020 Singapore; 20th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry April 01-02, 2020 London, UK; 13th European Biosimilars Congress 2020 April 01-02, 2020 London, UK; World Pharma Expo April 09-10, 2020 Bangkok, Thailand; 5th Pharmaceutical Chemistry Conference April 27-28, 2020 Prague, Czech Republic; 8th World Congress on Antibiotics, Antimicrobials & Antibiotic Resistance April 27-28, 2020 Singapore; 7th European Biopharma Congress April 27-28, 2020 Prague, Czech Republic; 19th International Conference on Pharmaceutics & Novel Drug Delivery Systems April 27-28, 2019 Dubai, UAE;
Related Societies:
The pharmaceutical and Toxicological industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany; 11th International Conference on Medicinal Chemistry and Pharmaceutical Technology April 01-02, 2019 Prague, Czech Republic; 15th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology March 18-19, 2019 Paris, France;10th European Conference on Predictive, Preventive & Personalized Medicine and Molecular Diagnostics August 29-30, 2019 London, UK; 22nd International Conference and Exhibition on Pharmaceutical Formulations June 03-04, 2019, London, UK; 6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance June 03-04, 2019 London, UK;
American Association of Pharmaceutical Scientists (AAPS) October 25 – 29, 2020 New Orleans, LA; St. ructural, Computational and Pharmacological Approaches for Studying GPCR Function, February 9 - 10, 2019, Ventura, CA, US; Sydney;7th FIP Pharmaceutical Sciences World Congress (PSWC) Smart Therapeutics for a Complex World May 22 – 27, 2020 Montreal, QC; 19th International Conference on Pharmaceutics & Novel Drug Delivery Systems April 27-28, 2019 Dubai, UAE; 3rd World Congress on Traditional and Complementary Medicine April 29-30, 2020 Istanbul, Turkey; 16th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology May 04-05, 2020 Amsterdam, Netherlands; Global summit on Cosmetic Surgery & Dermatology May 13-14, 2020 Tokyo, Japan; 30th Annual European Pharma Congress May 18-19, 2020 Berlin, Germany; 9th Annual Congress on Pharmaceutics & Drug Delivery Systems June 18-19, 2020 Geneva, Switzerland.
Related Societies:
Safety pharmacology evaluations are an essential step in assessing acute and potentially life-threatening risks of novel pharmaceuticals as part of an IND-enabling program. Second-tier safety pharmacology studies can be used to determine mechanistic effects on vital functions and evaluate potential adverse effects on organ systems such as renal and gastrointestinal systems.
7th International Conference and Exhibition on Natural Products and Medicinal Plants Research July 22-23 ,2020 Barcelona, Spain; 23rd International Conference and Exhibition on Pharmaceutical Formulations July 27-28, 2020 Zurich, Switzerland; 13th International Conference and Exhibition on Pharmacovigilance & Drug Safety July 27-28, 2020 Zurich ,Switzerland; 33rd World Congress on Pharmacology August 26-27, 2020 Barcelona, Spain; Innovation in Drug Design Techniques and Pharmacology October 19-20, 2020 | Paris, France; 11th Annual Biomarkers and Clinical Research Congress Mar 23-24 2020 | Dublin, Ireland; 2nd International Conference on Biosimilars & Pharmaceuticals February 12-13, 2020 Auckland, New Zealand; 6th International Conference on Polymer Chemistry April 13-14, 2020 Prague ,Czech Republic.
Related Societies:
Statistical analysis is one of the foundations of evidence-based clinical practice, a key in conducting new clinical research and in evaluating and applying prior research. In this paper, we review the choice of statistical procedures, analyses of the associations among variables and techniques used when the clinical processes being examined are still in process. We discuss methods for building predictive models in clinical situations, and ways to assess the stability of these models and other quantitative conclusions. Techniques for comparing independent events are distinguished from those used with events in a causal chain or otherwise linked. Attention then turns to study design, to the determination of the sample size needed to make a given comparison, and to statistically negative studies.
6th International Conference on Physical and Theoretical Chemistry March 18-19, 2020 Amsterdam, Netherlands; 16th European Organic Chemistry Congress March 18-19, 2020 London, UK; 8th Global Conference on Mass Spectrometry March 23-24, 2020 Osaka, Japan; 6th Edition of International Conference on Polymer Science and Technology April 01-02, 2020 Paris ,France; 20th World Congress on Nutrition and Food Chemistry April 13-14, 2020 London, UK; Green & Industrial Chemistry Congress April 17-18, 2020 London, United Kingdom; 12th International Conference & Expo on Chromatography Techniques April 20-21, 2020 Berlin, Germany; 34th Global Experts Meeting on Neonatal Nursing and Maternal Healthcare May 13-14, 2020 Tokyo, Japan; 8th International Conference and Exhibition on Materials Science and Chemistry May 18-19, 2020 Berlin, Germany.
Related Societies:
Adverse drug reactions can be considered a form of toxicity; however, toxicity is most commonly applied to effects of overingestion (accidental or intentional) or to elevated blood levels or enhanced drug effects that occur during appropriate use (eg, when drug metabolism is temporarily inhibited by a disorder or another drug). For information on toxicity of specific drugs see the table Symptoms and Treatment of Specific Poisons. Side effect is an imprecise term often used to refer to a drug’s unintended effects that occur within the therapeutic range.
Because all drugs have the potential for adverse drug reactions, risk-benefit analysis (analyzing the likelihood of benefit vs risk of ADRs) is necessary whenever a drug is prescribed.
In the US, 3 to 7% of all hospitalizations are due to adverse drug reactions. ADRs occur during 10 to 20% of hospitalizations; about 10 to 20% of these ADRs are severe. These statistics do not include the number of ADRs that occur in ambulatory and nursing home patients. Although the exact number of ADRs is not certain, ADRs represent a significant public health problem that is, for the most part, preventable.
International Conference on Psychology Education, Counseling, Psychotherapy and Recovery February 24-25, 2020 Rome, Italy; 2nd European Autism Congress February 28-29, 2020 Budapest, Hungary; European Psychologists & Psychiatrists Meeting February 28-29, 2020 Budapest, Hungary; 12th Worldwide Forum on Mental Health & Psychiatry March 07-08, 2020 Rome, Italy; 8th International Conference on  Mental Health and Human Resilience March 09-10, 2020 Rome, Italy; 16th World Congress on Psychiatric & Mental Health Nursing March 27-28, 2020 Toronto, Canada ;7th World Congress on Mental Health, Psychiatry and Wellbeing March 27-28, 2020 Barcelona, Spain; 32nd International Conference on Mental and Behavioral Health April 22-23, 2020 Kyoto, Japan.

Related Societies:
Biochemical pharmacology uses the methods of biochemistry, biophysics, molecular biology, structural biology, cell biology, and cell physiology to define the mechanisms of drug action and how drugs influence the organism by studies on intact animals, organs, cells, subcellular compartments and individual protein molecules. The biochemical pharmacologist also uses drugs as probes to discover new information about biosynthetic and cell signalling pathways and their kinetics, and investigates how drugs can correct the biochemical abnormalities that are responsible for human illness, thus enabling the elucidation of pathophysiological mechanisms that pave the way for further drug discover
3rd International Conference on Addiction & Psychiatry April 23-24, 2020 Amsterdam, Netherlands; 2nd World Depression Congress April 27-28, 2020 Istanbul, Turkey; 26th International Conference on Psychiatry, Mental Disorders & Psychosomatic Medicine April 27-28, 2020 Rome, Italy; 29th International Conference on Neuroscience, Psychiatry and Psychology Health May 04-05, 2020 Amsterdam, Netherlands; 3rd World Summit on Psychiatry, Mental Health Nursing and Healthcare May 08-09, 2020 Toronto, Canada; 35th International Conference on Psychiatry and Mental Health May 18 -19 ,2020 Osaka Japan; World Congress on Psychiatry and Psychology May 25-26, 2020 , Kyoto, Japan;
Related Societies:

 
 

Special Issues


  • Biochemistry & Pharmacology: Open Access
  • Journal of Clinical & Experimental Pharmacology
  • Cardiovascular Pharmacology: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref

See more at: https://pharmacology.pharmaceuticalconferences.com/
Posted by at 3 comments:
Subscribe to: Posts (Atom)